Makers Laboratories Limited
BSE: MAKERSL
Prev Close
146.6
Open Price
147
Volume
80
Today Low / High
147 / 149.85
52 WK Low / High
122 / 230
Range
142 - 156
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 149, reflecting a change of 2.4 (1.63711%). The expected target range on the BSE is 142 - 156. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Makers Laboratories Limited Graph
Makers Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Makers Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 149.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 149.00 | 150.49 | 135.44 - 165.54 |
| 151.98 | 121.58 - 182.38 | ||
| 153.47 | 107.43 - 199.51 | ||
| Bearish Scenario | 149.00 | 147.51 | 132.76 - 162.26 |
| 146.02 | 116.82 - 175.22 | ||
| 144.53 | 101.17 - 187.89 |
Overview of Makers Laboratories Limited
ISIN
INE987A01010
Industry
Medical - Pharmaceuticals
Vol.Avg
2,682
Market Cap
879,156,620
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of MAKERSL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2019-08-01 | August 01, 19 | 0.95947 | 0.95947 | 2019-08-02 | 2019-09-07 | |
| 2018-07-26 | July 26, 18 | 0.95947 | 0.95947 | 2018-07-27 | 2018-09-01 | |
| 2017-07-20 | July 20, 17 | 0.95947 | 0.95947 | 2017-07-21 | 2017-08-20 | |
| 2016-08-02 | August 02, 16 | 0.95947 | 0.95947 | |||
| 2015-07-28 | July 28, 15 | 0.95947 | 0.95947 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 120.75 Cr | 72.90 Cr | 47.85 Cr | 0.3962 | 0.00 Cr | 0.00 Cr | 3.60 Cr | 7.49 Cr | 12.92 | 19.48 Cr | 0.0620 |
| 2024-03-31 | 103.76 Cr | 65.57 Cr | 38.19 Cr | 0.3681 | 0.13 Cr | 1.51 Cr | -3.24 Cr | -6.26 Cr | -10.62 | 1.97 Cr | -0.0604 |
| 2023-03-31 | 100.84 Cr | 61.86 Cr | 38.98 Cr | 0.3866 | 0.26 Cr | 1.15 Cr | -0.95 Cr | -4.75 Cr | -7.90 | 4.88 Cr | -0.0471 |
| 2022-03-31 | 126.56 Cr | 74.12 Cr | 52.44 Cr | 0.4143 | 0.53 Cr | 1.17 Cr | 15.01 Cr | 4.98 Cr | 10.12 | 21.41 Cr | 0.0393 |
| 2021-03-31 | 68.28 Cr | 36.83 Cr | 31.45 Cr | 0.4606 | 0.24 Cr | 0.83 Cr | 3.52 Cr | -0.33 Cr | -0.64 | 8.92 Cr | -0.0048 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.65 Cr | 147.95 Cr | 32.76 Cr | 70.5059 Cr | 5.06 Cr | 4.42 Cr | 34.04 Cr | 73.72 Cr | 0.00 Cr | 0.00 Cr | 1.72 Cr | 21.2005 Cr |
| 2024-03-31 | 0.41 Cr | 161.26 Cr | 56.92 Cr | 63.0465 Cr | 19.49 Cr | 19.08 Cr | 38.35 Cr | 85.75 Cr | 1.83 Cr | 0.00 Cr | 0.15 Cr | 37.1728 Cr |
| 2023-03-31 | 0.72 Cr | 152.30 Cr | 42.62 Cr | 69.2013 Cr | 13.42 Cr | 12.69 Cr | 31.32 Cr | 84.29 Cr | 2.41 Cr | 0.00 Cr | 0.09 Cr | 27.5375 Cr |
| 2022-03-31 | 2.31 Cr | 144.33 Cr | 46.24 Cr | 59.5804 Cr | 19.40 Cr | 17.09 Cr | 23.84 Cr | 77.45 Cr | 3.47 Cr | 0.00 Cr | 0.22 Cr | 33.0076 Cr |
| 2021-03-31 | 5.27 Cr | 136.19 Cr | 49.62 Cr | 54.1287 Cr | 16.59 Cr | 11.32 Cr | 27.47 Cr | 71.23 Cr | 0.67 Cr | 0.00 Cr | 2.54 Cr | 33.1233 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -4.7383 Cr | 19.3552 Cr | -14.7880 Cr | -8.6794 Cr | 0.0000 Cr | 0.6459 Cr | -3.9411 Cr | 7.4907 Cr | -8.3126 Cr | 0.0000 Cr | -0.2318 Cr |
| 2024-03-31 | -0.0993 Cr | -7.4581 Cr | 7.2490 Cr | -5.7823 Cr | -0.3084 Cr | 0.4140 Cr | -6.6229 Cr | -6.2641 Cr | 8.2381 Cr | -0.6294 Cr | -2.4837 Cr |
| 2023-03-31 | -8.6198 Cr | 1.2525 Cr | 5.7812 Cr | -21.5271 Cr | -1.5861 Cr | 0.7224 Cr | -12.9073 Cr | -0.8385 Cr | -5.7380 Cr | -0.6294 Cr | -7.4771 Cr |
| 2022-03-31 | 18.4985 Cr | -21.7916 Cr | 0.3284 Cr | 8.6103 Cr | -2.9647 Cr | 2.3085 Cr | -9.8882 Cr | 15.6883 Cr | 2.8931 Cr | -0.6294 Cr | 3.6229 Cr |
| 2021-03-31 | -0.3292 Cr | 0.0000 Cr | 0.0000 Cr | -0.3292 Cr | 4.5758 Cr | 5.5378 Cr | 0.0000 Cr | -0.3292 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 33.90 Cr | 13.97 Cr | 19.93 Cr | 0.5878 | 16.33 Cr | -0.05 Cr | -0.08 | 3.38 Cr | -0.0013 |
| 2024-12-31 | 27.69 Cr | 13.31 Cr | 14.38 Cr | 0.5193 | 0.00 Cr | -0.30 Cr | -0.50 | 2.18 Cr | -0.0107 |
| 2024-09-30 | 29.57 Cr | 17.24 Cr | 12.33 Cr | 0.4170 | 0.89 Cr | 8.82 Cr | 14.94 | 12.81 Cr | 0.2982 |
| 2024-06-30 | 29.59 Cr | 19.40 Cr | 10.19 Cr | 0.3445 | 0.53 Cr | -0.98 Cr | -1.67 | 1.30 Cr | -0.0333 |
| 2024-03-31 | 27.81 Cr | 20.70 Cr | 7.11 Cr | 0.2558 | -0.29 Cr | -1.29 Cr | -2.18 | 1.29 Cr | -0.0462 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.65 Cr | 0.00 Cr | 0.65 Cr | 27.63 Cr | 34.04 Cr | 68.27 Cr | 73.72 Cr | 147.95 Cr | 32.76 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 7.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -113.41 Cr |
| 2024-09-30 | 1.13 Cr | 5.94 Cr | 7.68 Cr | 23.07 Cr | 29.80 Cr | 67.50 Cr | 76.67 Cr | 150.11 Cr | 36.70 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 4.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -104.34 Cr |
| 2024-03-31 | 2.23 Cr | 2.81 Cr | 5.04 Cr | 20.87 Cr | 33.80 Cr | 69.80 Cr | 85.75 Cr | 161.26 Cr | 56.92 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -0.30 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 8.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.98 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -1.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -1.54 Cr | 2.31 Cr | 0.00 Cr | 0.00 Cr | 2.31 Cr | 4.72 Cr | 2.41 Cr | 0.00 Cr | 2.31 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-03-30 | March 30, 22 | 521:500 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born: 1975
Gender: male
Year Born: 1948
Gender: male
Year Born: 1972
Gender: male
Year Born: 1967
Gender: male
Year Born: 1975
Gender: male
Year Born:
FAQs about Makers Laboratories Limited
The CEO is Saahil U. Parikh.
The current price is ₹149.00.
The range is ₹122-230.
The market capitalization is ₹87.92 crores.
The P/E ratio is 11.26.
The company operates in the Healthcare sector.
Overview of Makers Laboratories Limited (ISIN: INE987A01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹87.92 crores and an average daily volume of 2,682 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.